Goldspan Health review

Goldspan links its storefront to an Altro-hosted product catalog. The current full-dose compounded semaglutide and tirzepatide offers explicitly bill every 28 days. The annualized calendar-month equivalents are about $248.76 and $324.81 respectively. Those comparison figures are not the amount charged each calendar month. Starting with a payment on day zero, uninterrupted 28-day renewals produce 14 payments during the first 365 days. Required testing can add another expense. The tirzepatide cost guide explains how to compare charge intervals without treating them as interchangeable. The price is tied to a specific product and selected plan, rather than an unlimited right to any formulation or dose. Confirm the prescribed preparation, amount supplied, refill conditions and complete charge before checkout. The product description includes clinical review, injection supplies, shipping and access to the care team, but that does not establish that all future tests or replacement shipments are included. Product advertising is not evidence that a particular compounded preparation has the same effects as an approved brand. The semaglutide guide separates approved products from compounded preparations.

Testing deserves special attention because the pages disagree in scope. The general homepage calls labs optional and encouraged. The specific GLP-1 product pages instead require a panel 60 to 90 days after initiation and annually thereafter. Treat the product-specific requirement as the relevant question for that prescription. Goldspan describes testing through a partner or uploading outside results, but the reviewed offer does not establish a complete laboratory price. Ask which tests qualify, whether existing results are recent enough, how results are reviewed and what happens to a paid refill if testing is incomplete. An inexpensive medication quote is less useful if the required monitoring is missing from the budget.

The terms say charges occur at checkout. The refund policy makes orders final once placed, with a full refund if the clinician completes the intake review and declines to prescribe. This is a narrow clinical-denial exception, rather than a trial period after receiving medication. The policy separately asks customers to report lost or transit-damaged shipments within seven days of delivery so the company can work with the pharmacy on a replacement. That process does not promise a discretionary cash refund. Obtain the next processing date and written cancellation instructions before relying on a pause or cancellation to stop an order already underway.

The delivery timeline contains several stages. The hosted product page describes clinical review in one to two business days and pharmacy preparation taking three to five business days. Its broader timeline describes shipment around days five to seven with two-day transit. Two-day shipping therefore does not mean delivery two days after checkout. A 15-minute video appointment may be required depending on history or location; the intake does not guarantee either a prescription or an entirely written consultation. Ask how to reach the actual treating clinician for side effects, missed deliveries or a change in treatment rather than treating ordinary support messaging as urgent medical care. Goldspan identifies Altro Health as its clinical infrastructure partner, while its terms describe an independent medical group and pharmacies. The public statements about board certification, professional training and 503A or 503B sourcing are company disclosures. They do not independently establish the assigned clinician, a particular pharmacy license, facility registration or whether a specific preparation can lawfully be supplied to you. A 503A pharmacy and a 503B outsourcing facility also have different regulatory frameworks; neither category makes a compounded drug FDA-approved. Ask for the treating practice and dispensing location before deciding whether those arrangements meet your needs.

The current hosted catalog also lists NAD+, sermorelin, glutathione, topical GHK-Cu and hormone products, including progesterone. A listed therapy or named clinical advisor does not prove an anti-aging, recovery or inflammation benefit. Lower-dose GLP-1 offerings require the same separation between a sales description and clinical evidence; the ordinary full-dose price cannot be assigned to a different microdose formulation. Product and state availability still require confirmation despite the homepage’s broad national language. The tirzepatide comparison can help organize price and care questions after the prescription-specific requirements are clear.